We next determined the in vivo anti-leukemia efficacy of adavosertib and panobinostat in the OCI-AML3 xenograft model as well as in AML PDX (patient-derived xenograft) models expressing mtNPM1 and FLT3-ITD in NSG mice. The gene discussed is FLT3; the disease is acute myeloid leukemia.